Drugs / RGB-14-P
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05087030 | Sep 2021 → Oct 2023 | postmenopausal osteoporosis | Gedeon Richter Plc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RGB-14-P | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05087030 ↗ |
| Route | Subcutaneous | “subcutaneous (SC) injection of RGB-14-P” NCT05087030 ↗ |